M&T Bank Corp Has $10.86 Million Stock Holdings in HCA Healthcare, Inc. $HCA

Key Points

• M&T Bank Corp boosted its stake in HCA by 172% in Q4, owning 23,253 shares after buying 14,703 more, valued at about $10.856 million per its latest SEC filing.
• HCA's Q1 results were mixed—EPS of $7.15 slightly missed estimates while revenue rose 4.3% to $19.11B and operating margin was ~12%, but softer surgical volumes, rising expenses and FY26 guidance of $29.10–$31.50 pressured the stock down roughly 8.6%.
• Institutional investors hold 62.73% of HCA and analysts rate the stock a "Moderate Buy" with an average price target of $534.41, even as insiders have reduced positions (about 15,214 shares sold worth ~$7.8M in the past 90 days).

M&T Bank Corp grew its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 172.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 23,253 shares of the company's stock after purchasing an additional 14,703 shares during the quarter. M&T Bank Corp's holdings in HCA Healthcare were worth $10,856,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Pacer Advisors Inc. lifted its stake in shares of HCA Healthcare by 6,115.3% in the third quarter. Pacer Advisors Inc. now owns 911,096 shares of the company's stock worth $388,309,000 after acquiring an additional 896,437 shares during the period. Viking Global Investors LP lifted its stake in shares of HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company's stock worth $717,214,000 after acquiring an additional 690,773 shares during the period. Danske Bank A S acquired a new position in shares of HCA Healthcare in the third quarter worth approximately $115,530,000. Zurich Insurance Group Ltd FI lifted its stake in shares of HCA Healthcare by 3,755.9% in the third quarter. Zurich Insurance Group Ltd FI now owns 269,912 shares of the company's stock worth $115,036,000 after acquiring an additional 262,912 shares during the period. Finally, Mondrian Investment Partners LTD acquired a new position in shares of HCA Healthcare in the third quarter worth approximately $106,605,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Revenue and demand beat/strength: Q1 revenue rose ~4.3% to $19.11B and the company cited strong medical care demand; some outlets note the company beat profit estimates on service demand. HCA Healthcare beats quarterly profit estimates on medical care demand
• Positive Sentiment: Margins still meaningful: HCA reported a ~12% operating margin in Q1, showing underlying profitability despite a dynamic operating environment. HCA posts 12% operating margin in Q1: 8 things to know
• Neutral Sentiment: Official results and call: HCA reported EPS of $7.15 and released its earnings call transcript and press release (revenue in line with consensus). These documents give full context on volumes, mix and expense items for analysts. HCA Healthcare Reports First Quarter 2026 Results Q1 2026 Earnings Call Transcript
• Negative Sentiment: Volume weakness weighed heavily: Surgical volumes softened and total volumes missed seasonal expectations, which traders flagged as the main reason for the share decline despite a near-term beat on profits. HCA Healthcare stock plunges nearly 8% on weak volume trends despite Q1 beat
• Negative Sentiment: EPS/guidance miss vs. street: Reported EPS was roughly flat to estimates (small miss on some models) and FY26 guidance of $29.10–$31.50 EPS (and revenue range) sits slightly below consensus, prompting downward revisions. HCA Trading/Guidance Summary
• Negative Sentiment: Policy and longer-term growth concerns: Analysts warn policy headwinds (Medicaid/ACA subsidy rollbacks) may limit admissions growth to low single digits over coming years — a reason at least one shop trimmed upside and moved to Hold. Policy Pressures May Be Limiting Admissions (Upgrade)
• Negative Sentiment: Rising expenses and margin retracement: Several reports cite higher expenses and a ~50 bps margin retracement in the quarter, which combined with volume softness amplifies near-term earnings risk. Q1 Earnings Miss on Rising Expenses

HCA Healthcare Stock Down 8.6%

NYSE HCA opened at $433.04 on Friday. The company has a market cap of $96.81 billion, a price-to-earnings ratio of 15.26, a P/E/G ratio of 1.59 and a beta of 1.36. HCA Healthcare, Inc. has a 52 week low of $321.39 and a 52 week high of $556.52. The business has a 50 day moving average price of $505.45 and a 200-day moving average price of $485.06.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). The firm had revenue of $19.11 billion for the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The company's revenue was up 4.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities research analysts anticipate that HCA Healthcare, Inc. will post 30.15 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. HCA Healthcare's payout ratio is presently 10.99%.

Insider Buying and Selling

In related news, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the transaction, the senior vice president owned 44,379 shares of the company's stock, valued at $22,411,395. The trade was a 8.27% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Michael S. Cuffe sold 1,500 shares of the business's stock in a transaction on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total value of $747,135.00. Following the completion of the transaction, the executive vice president directly owned 30,003 shares in the company, valued at approximately $14,944,194.27. This represents a 4.76% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 15,214 shares of company stock worth $7,797,595 in the last ninety days. Corporate insiders own 1.50% of the company's stock.

Analyst Upgrades and Downgrades

HCA has been the topic of several recent analyst reports. Deutsche Bank Aktiengesellschaft boosted their price target on HCA Healthcare from $500.00 to $558.00 and gave the company a "buy" rating in a research note on Wednesday, January 28th. Truist Financial boosted their price target on HCA Healthcare from $520.00 to $546.00 and gave the company a "buy" rating in a research note on Wednesday, January 28th. Oppenheimer boosted their price target on HCA Healthcare from $500.00 to $540.00 and gave the company an "outperform" rating in a research note on Wednesday, January 28th. Wall Street Zen lowered HCA Healthcare from a "strong-buy" rating to a "buy" rating in a research note on Saturday, February 14th. Finally, Robert W. Baird decreased their price objective on HCA Healthcare from $450.00 to $442.00 and set a "neutral" rating for the company in a report on Wednesday, April 15th. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $534.41.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.